JP2023503380A5 - - Google Patents

Info

Publication number
JP2023503380A5
JP2023503380A5 JP2022532785A JP2022532785A JP2023503380A5 JP 2023503380 A5 JP2023503380 A5 JP 2023503380A5 JP 2022532785 A JP2022532785 A JP 2022532785A JP 2022532785 A JP2022532785 A JP 2022532785A JP 2023503380 A5 JP2023503380 A5 JP 2023503380A5
Authority
JP
Japan
Prior art keywords
lys
hyp
dopa
pro
thr
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022532785A
Other languages
English (en)
Japanese (ja)
Other versions
JP7895852B2 (ja
JP2023503380A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2020/133436 external-priority patent/WO2021110061A1/en
Publication of JP2023503380A publication Critical patent/JP2023503380A/ja
Publication of JP2023503380A5 publication Critical patent/JP2023503380A5/ja
Application granted granted Critical
Publication of JP7895852B2 publication Critical patent/JP7895852B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022532785A 2019-12-02 2020-12-02 ペプチド及び炎症の治療におけるそれらの使用 Active JP7895852B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CNPCT/CN2019/122391 2019-12-02
CNPCT/CN2019/122391 2019-12-02
PCT/CN2020/133436 WO2021110061A1 (en) 2019-12-02 2020-12-02 Peptides and their use in the treatment of inflammation

Publications (3)

Publication Number Publication Date
JP2023503380A JP2023503380A (ja) 2023-01-27
JP2023503380A5 true JP2023503380A5 (cg-RX-API-DMAC7.html) 2023-12-11
JP7895852B2 JP7895852B2 (ja) 2026-07-28

Family

ID=76221459

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2022532756A Pending JP2023503374A (ja) 2019-12-02 2020-12-02 新規なペプチドと多糖類とのコンジュゲート
JP2022532785A Active JP7895852B2 (ja) 2019-12-02 2020-12-02 ペプチド及び炎症の治療におけるそれらの使用
JP2026005938A Pending JP2026067913A (ja) 2019-12-02 2026-01-16 新規なペプチドと多糖類とのコンジュゲート

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2022532756A Pending JP2023503374A (ja) 2019-12-02 2020-12-02 新規なペプチドと多糖類とのコンジュゲート

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2026005938A Pending JP2026067913A (ja) 2019-12-02 2026-01-16 新規なペプチドと多糖類とのコンジュゲート

Country Status (9)

Country Link
US (2) US20240218016A1 (cg-RX-API-DMAC7.html)
EP (2) EP4069713A4 (cg-RX-API-DMAC7.html)
JP (3) JP2023503374A (cg-RX-API-DMAC7.html)
KR (2) KR20220117256A (cg-RX-API-DMAC7.html)
CN (2) CN114929726A (cg-RX-API-DMAC7.html)
AU (2) AU2020396818A1 (cg-RX-API-DMAC7.html)
CA (2) CA3160127A1 (cg-RX-API-DMAC7.html)
TW (2) TW202133882A (cg-RX-API-DMAC7.html)
WO (2) WO2021110063A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4028409A4 (en) 2019-09-14 2023-10-11 EnliTISA (Shanghai) Pharmaceutical Co., Ltd. NEW PEPTIDES
JP2026506026A (ja) * 2023-02-13 2026-02-20 エンリティザ(シャンハイ)ファーマシューティカル カンパニー リミテッド 新規多機能オリゴペプチド
AU2024312518A1 (en) * 2023-06-22 2026-01-22 Enlitisa (Shanghai) Pharmaceutical Co., Ltd. New multi-functional oligopeptides
WO2025195444A1 (en) 2024-03-20 2025-09-25 Enlitisa (Shanghai) Pharmaceutical Co., Ltd. New use of peptides derived from vasoactive intestinal peptide

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02500082A (ja) * 1987-03-12 1990-01-18 ジェネックス・コーポレーション 遺伝子操作された生物による生物粘着物質前駆体タンパク質類似体の生産
US5229490A (en) * 1987-05-06 1993-07-20 The Rockefeller University Multiple antigen peptide system
US4908404A (en) * 1988-08-22 1990-03-13 Biopolymers, Inc. Synthetic amino acid-and/or peptide-containing graft copolymers
US5616311A (en) * 1991-01-15 1997-04-01 Hemosphere, Inc. Non-crosslinked protein particles for therapeutic and diagnostic use
EP0831793A4 (en) * 1995-06-06 2000-11-15 Hemosphere Inc PROTEIN PARTICLES FOR THERAPEUTIC AND DIAGNOSTIC USE
WO2000015789A1 (en) * 1998-09-09 2000-03-23 United States Surgical Corporation Recombinant bioadhesive protein analogs comprising hydroxyproline
US20030191291A1 (en) * 2000-09-08 2003-10-09 Kochendoerfer Gerd G. Synthetic erythropoiesis stimulating proteins
CU23011A1 (es) * 2000-11-03 2004-12-17 Ct Ingenieria Genetica Biotech Método de obtención de estructuras antigénicas quemétodo de obtención de estructuras antigénicas que potencian la reactividad cruzada específica y su potencian la reactividad cruzada específica y su uso en formulaciones uso en formulaciones
JP5133048B2 (ja) * 2004-02-27 2013-01-30 ノースウエスタン ユニバーシティ 重合化合物及び関連した使用方法
WO2007124593A1 (en) * 2006-05-02 2007-11-08 Universite Laval Branched peptide amplification and uses thereof
WO2009001220A2 (en) * 2007-06-26 2008-12-31 Universitetet I Oslo Functionalization of microscopy probe tips
US20130224269A1 (en) * 2010-11-15 2013-08-29 Avon Products, Inc. Biofunctional Anchored Extended-Wear Cosmetics
JP6202669B2 (ja) * 2013-04-26 2017-09-27 国立研究開発法人国立循環器病研究センター ペプチド及びその複合体、組織修復用スキャフォールド及びその表面処理方法、並びに表面処理液又は処理液のセット
KR101677097B1 (ko) * 2015-03-18 2016-11-18 포항공과대학교 산학협력단 내부 장기의 접합 및 누공, 천공 또는 문합부 누출 치료용 접착 실란트
MX2017013196A (es) * 2015-04-17 2018-06-19 Symic Ip Llc Bioconjugados y usos de los mismos.
KR102468524B1 (ko) * 2015-07-20 2022-11-18 장인 벵트 아이. 사무엘손 인스티튜트 오브 라이프 사이언스 컴퍼니 리미티드 멜라닌과 관련된 질환의 치료 및 예방에서의 홍합 접착 단백질 제품의 용도
BR112018000953A2 (pt) * 2015-07-20 2018-09-11 Bengt I. Samuelsson Institute Of Life Science Research produto de proteína adesiva de mexilhão e aplicações do mesmo na supressão de inflamações de pele
WO2017028025A1 (zh) * 2015-08-14 2017-02-23 江阴市本特塞缪森生命科学研究院有限公司 贻贝粘蛋白产品及其抑制粘膜炎症的应用
WO2017088177A1 (zh) * 2015-11-27 2017-06-01 江阴市本特塞缪森生命科学研究院有限公司 贻贝粘蛋白产品及其预防和抑制神经炎症的应用
KR101807593B1 (ko) * 2015-12-30 2017-12-11 포항공과대학교 산학협력단 흉터 최소화 상처 재생 촉진용 재조합 폴리펩타이드 및 이를 포함하는 생체 접착 소재
AR110299A1 (es) * 2016-12-02 2019-03-13 Sanofi Sa Conjugados que comprenden un agonista dual de glp-1 / glucagón, un conector y ácido hialurónico
CA3068818A1 (en) * 2017-07-05 2019-01-10 Jiangyin Mucocare Pharmaceutical Co., Ltd Topical formulations comprising montelukast and combinations with mussel adhesive proteins
CN110139662B (zh) * 2017-07-05 2022-03-18 江阴贝瑞森制药有限公司 肽的抗炎用途
KR102010051B1 (ko) * 2017-09-20 2019-08-12 주식회사 포스코 카테콜 치환된 음이온성 고분자로부터 형성된 코아세르베이트, 이를 포함하는 접착제 및 이의 제조방법
KR102954778B1 (ko) * 2018-03-09 2026-04-20 발리터 인코포레이티드 관절 염증의 지속적인 관절내 치료를 위한 다가 펩티드 컨쥬게이트
MA52794A (fr) * 2018-05-28 2021-04-14 Jiangyin Usun Pharmaceutical Co Ltd Nouvelle utilisation pharmaceutique
HUE062848T2 (hu) * 2018-09-14 2023-12-28 Enlitisa Shanghai Pharmaceutical Co Ltd Montelukaszt és peptidek konjugátumai

Similar Documents

Publication Publication Date Title
EP2575816B1 (en) Combination therapy for skin disorders
JP2022500437A5 (cg-RX-API-DMAC7.html)
TWI250163B (en) Combretastatin A-4 phosphate prodrug mono-and di-organic amine salts, mono-and di-amino acid salts, and mono-and di-amino acid ester salts
US12612430B2 (en) Peptides
TW201441186A (zh) 用於治療纖維化之經取代之芳族化合物及相關方法
JP2024517738A5 (cg-RX-API-DMAC7.html)
EP2660247A2 (en) High penetration prodrug compositions of peptides and peptide-related compounds
IE903302A1 (en) Topical preparation for treatment of aphthous ulcers and¹other lesions
WO2021110061A1 (en) Peptides and their use in the treatment of inflammation
CA2706738A1 (en) Treatment of mixed pathogen infections
JP2025118775A5 (cg-RX-API-DMAC7.html)
WO2023169557A1 (zh) 一种次黄碱衍化合物在制备治疗肺纤维化药物中的应用
CN120731082A (zh) 新多功能寡肽
WO2003066572B1 (en) Polyamine compounds and compositions for use in conjunction with cancer therapy
JP2003522786A5 (cg-RX-API-DMAC7.html)
JP2803477B2 (ja) ヘキサペプチド
JP2004510775A5 (cg-RX-API-DMAC7.html)
JPH11505243A (ja) Aii受容体アンタゴニストの新規な薬理学的使用
JP2001505544A (ja) フルオシノニド含有経口組成物
JP2022543056A5 (cg-RX-API-DMAC7.html)
RU2021105972A (ru) Новые конъюгаты монтелукаста и пептидов
CN1700914A (zh) 口腔等粘膜中的炎性疾病的预防或治疗剂
JP7836044B2 (ja) 抗菌性ジペプチド化合物
JPH09502427A (ja) オキシトシン拮抗薬活性を示すペプチド
HK40081672A (en) High penetration prodrug compositions of peptides and peptide related compounds